Eli Lilly and Co (NYSE:LLY)

113.83
Delayed Data
As of Nov 16
 +1.63 / +1.45%
Today’s Change
73.69
Today|||52-Week Range
116.61
+34.77%
Year-to-Date
LLY Regular Dividend: LLY began trading ex-dividend on 11/14/18. A $0.5625 dividend will be paid to shareholders of record as of 11/15/18.

Today’s Trading

Previous close112.20
Today’s open111.68
Day’s range111.67 - 114.30
Volume4,766,426
Average volume (3 months)4,175,183
Market cap$118.9B
Data as of 4:02pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)-107.34%
Earnings growth (this year)+29.78%
Earnings growth (next 5 years)+12.60%
Revenue growth (last year)+7.77%
P/E ratio242.2
Price/Sales3.88
Price/Book10.65

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+1.31+1.85%
SNYSanofi+0.53+1.19%
ABBVAbbVie+1.39+1.54%
AZNAstraZeneca-0.73-1.76%
Data as of 4:04pm ET, 11/16/2018

Financials

Next reporting dateFebruary 13, 2019
EPS forecast (this quarter)$1.34
Annual revenue (last year)$22.9B
Annual profit (last year)-$204.1M
Net profit margin-0.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP-Biotechnology &
Autoimmunity Research
Thomas F. Bumol
Corporate headquarters
Indianapolis, Indiana

Forecasts